N/A
N=23
Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) Patients
Asthma · Chronic Obstructive Pulmonary Disease
Bottom Line
View on ClinicalTrials.gov: NCT02447575 ↗Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Oct 2020
Primary outcome: Primary: Inhaler Use Correctness — 3.52 correct steps
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Education on Use of MDI (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Baylor College of Medicine
- Primary completion
- Jul 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Inhaler Use Correctness |
3.52 | — |
Summary
Metered Dose Inhaler (MDI) and Dry Powdered Inhaler (DPI) are the two most common devices used to deliver medicine in conditions such as asthma and chronic obstructive pulmonary disease. It is well-known that most patients do not use correct technique when using a metered dose inhaler. This leads to poor control of their disease. This study is being done so the investigators can record the patient using the metered dose inhaler before and after a short teaching session. This information will be fed into an invitro system (device) to allow the researchers to study the effect of error on drug delivery. The device being used is the Rice R3 electronic flowmeter.
Eligibility Criteria
Inclusion Criteria
- Patients with a physician diagnosis of asthma or COPD taking inhaled medications using MDI
- Age >18 years
- Able to read and sign consent document
Exclusion Criteria
- Patients having acute exacerbation
- Patients who are unable to take medication from an MDI
Data sourced from ClinicalTrials.gov (NCT02447575). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.